Modified PRISMA diagram showing articles reviewed and main reasons for exclusion. by Helena R. A. Feasey (9238957)

Subjects:

Characteristics of included studies. by Helena R. A. Feasey (9238957)

Subjects:

Risk of bias and quality assessments for included studies. by Helena R. A. Feasey (9238957)

Subjects:

HIV status of TB cases by sex in Suhum Municipal. by Haruna M. Salisu (12988084)

Subjects:

Risk factors for mucormycosis among never-hospitalised COVID-19 patients, multi-centric case-control study of post-COVID rhino-orbito-cerebral mucormycosis, India, 2021. by Manickam Ponnaiah (294619)

Subjects:

Risk factors for mucormycosis among ever-hospitalised COVID-19 patients, multi-centric case-control study of post-COVID rhino-orbito-cerebral mucormycosis, India, 2021. by Manickam Ponnaiah (294619)

Subjects:

Directed acyclic graph of Post COVID-19 rhino orbito cerebral mucormycosis for (a) ever-hospitalised and (b) never-hospitalised patients. by Manickam Ponnaiah (294619)

Subjects:

Average stability values (mean ± standard deviation) and statistical results. by Hyung Suk Yang (20442438)

Sampling cases from the 2015–16 MDHS. by Khaing Zar Lwin (12456207)

Prediction results of hepatitis E cases by all the models. by Yi Feng (29944)

Image 11_Atypical bilateral papilledema during the puerperium: a case report.jpeg by Ligang Jiang (5664820)

“…Background<p>To analyze a case of atypical bilateral papilledema in a puerperium woman, and to explore the pathogenic mechanism of pregnancy-related physiological changes, blood hypercoagulable state, immune abnormalities and abnormal structure of intracranial venous sinus, so as to provide reference for early diagnosis and intervention of similar cases.…”

Table11_LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.XLSX by Fulin Guan (8161608)

“…Inhibition of RP11-59J16.2 or overexpression of MCM2, CCK-8 assay and Annexin V FITC/PI apoptosis assay kit results showed that RP11-59J16.2 could reduce cell viability, aggravate apoptosis and increase Tau phosphorylation in AD cell model by inhibiting MCM2. …”

The relative change in incident cases of RA among AYAs between 1990 and 2019. by Ruibo Li (2063167)

Individual stability values for different gait events under various conditions. by Hyung Suk Yang (20442438)

Decreasing genome breadth of coverage in samples with high Cq values. by Paul Y. Kim (7491026)

Characteristics of the included studies. by Konstantinos S. Kechagias (11757239)

Subjects:

PRISMA flowchart. by Konstantinos S. Kechagias (11757239)

Subjects:

Active spread of mtDNAs in the network can increase and decrease cell-to-cell variability from cell divisions. by Robert C. Glastad (10692277)

“…Rows show different values of initial mutant proportion, with <i>h</i> = 0.1 in the top row and <i>h</i> = 0.5 in the bottom row. …”

Background characteristics of cases and controls. by Sishir Poudel (20691519)

“…The mean age of cases and controls was 48.5 years (SD = 16.5) and 48 years (SD = 16.9) respectively. 38 were rapid ascenders, and 88 were slow ascenders. …”

Comparison of estimated epidemic risks (based on data available as of March 16, 2020) and reported increases in cases at the county level between March 16 and March 23, 2020. by Emily M. Javan (15194865)

Subjects: